A new procedure for treating pain at Mercy Hospital Washington is helping reduce the number of patients relying on opioids ...

Here's a look at how each federal party has been framing the toxic drug crisis and a fact check on some of their proposed policies.

Pacira Biosciences has authorized a share buyback program of up to $300 million. The developer of non-opioid pain relievers said Thursday the repurchase program replaces a previous $150 million ...

This crisis doesn’t discriminate. It affects working parents, young people and seniors — many of whom end up dependent ...

The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While questions remain about its cost, adoption, and long-term efficacy, its novel ...

If benzos and barbies aren't available, then it's down to the muscle relaxants, anticonvulsants and blood-pressure medications.

Scientists develop lab-grown model of the human sensory pathway to investigate how pain signals are transmitted to the brain.

The Trump administration's plan to address the opioid crisis focuses on preventing overdose deaths, but neglects the opportunity to prevent addiction in the first place, and instead relies on border ...

Researchers at Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center have identified an effective pain management ...

How could a non-opioid painkiller improve the lives of people with chronic pain? What makes a non-opioid painkiller safer ...

New research suggests that cancer patients referred for outpatient palliative care may not be receiving adequate treatment for pain.